Bronwen Bastone - Mar 1, 2024 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief People Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Mar 1, 2024
Transactions value $
$28,637
Form type
4
Date filed
3/5/2024, 08:20 PM
Previous filing
Jan 10, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +105K +67.99% $0.00 258K Mar 1, 2024 Direct F1
transaction ENFN Class A Common Stock Award $45.2K +5.21K +2.02% $8.67 264K Mar 1, 2024 Direct F2
transaction ENFN Class A Common Stock Tax liability -$16.5K -1.91K -0.72% $8.67 262K Mar 1, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The RSUs will vest in full as follows: 8,651, 8,651, 78,651 and 8,650 on each of March 1, 2025, 2026, 2027 and 2028.
F2 Consists of fully vested shares issued under the Plan (the "Vested Shares").
F3 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Vested Shares to the reporting person; not an open market transaction.